companydata.dkcompanydata.dk

CYTOVAC A/S: Financial statements 2022

CVR: 31262666

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -6,277,000 compared with DKK -13,352,000 the year before. Equity in the 2022 report amounted to DKK -73,260,000. The company had 8 employees in the financial year.

Revenue
DKK 0
Profit/Loss
DKK -6,277,000
Equity
DKK -73,260,000
Total Assets
DKK 3,225,000
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220--6.3M-73.3M8
2021960K--13.4M-67M-
20201M--15.7M-53.6M-
2019---34.1M-37.9M-
2018---30.4M-3.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CYTOVAC A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

CYTOVAC A/S: The 2021 annual report is outJun 22, 2022

CYTOVAC A/S has published its annual report for 2021. Revenue came to DKK 960,000, and the net result was DKK -13,352,000.

About CYTOVAC A/S

CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.

Source: annual report 2023, Danish Business Authority